PRF Technologies (PRFX) Net Cash Flow (2020 - 2024)
PRF Technologies (PRFX) recorded quarterly Net Cash Flow of $3.5 million in Q2 2024, up 195.22% on a QoQ basis from -$3.7 million in Q1 2024, and up 217.38% year-over-year from $1.1 million in Q3 2023.
PRF Technologies (PRFX) Net Cash Flow (2020 - 2024) Analysis & Trends
PRF Technologies has disclosed Net Cash Flow across 5 years of filings, most recently posting $3.5 million for Q2 2024.
- Quarterly Net Cash Flow rose 217.38% year-over-year to $3.5 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was $3.5 million (up 1107.19% YoY) and the FY2025 annual result came in at -$1.1 million, up 70.33% from the prior year.
- Net Cash Flow climbed to $3.5 million in Q2 2024, from -$3.7 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $2.7 billion in Q3 2021 and troughed at -$2.7 billion in Q4 2021.
- A 5-year average of $389166.7 and a median of -$661500.0 in 2020 frame the typical range for Net Cash Flow.
- Biggest YoY gain for Net Cash Flow was 15493.58% in 2021; the steepest drop was 132332.97% in 2021.
- Tracing PRFX's Net Cash Flow over 5 years: stood at -$2.0 million in 2020, then plunged by 132332.97% to -$2.7 billion in 2021, then jumped by 99.89% to -$2.8 million in 2022, then surged by 116.51% to $469000.0 in 2023, then surged by 651.6% to $3.5 million in 2024.
- Business Quant data shows PRFX's Net Cash Flow at $3.5 million in Q2 2024, -$3.7 million in Q1 2024, and $469000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | 3.53 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | 469,000.00 |
| Dec 31, 2023 | 469,000.00 |
| Sep 30, 2023 | 2.41 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Sep 30, 2022 | -6.92 Mn |
| Sep 30, 2022 | -6.92 Mn |
| Jun 30, 2022 | -1.59 Mn |
| Jun 30, 2022 | -1.59 Mn |
| Mar 31, 2022 | -1.11 Mn |
| Mar 31, 2022 | -1.11 Mn |